D. E. Shaw & Co., Inc. Replimune Group, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Replimune Group, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 931,780 shares of REPL stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

931,780

Previous 997,786 6.62%

Holding current value

$10.2 Million

Previous $8.15 Million 2.88%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $330,690 - $624,416	-66,006 Reduced 6.62%	931,780 $8.39 Million
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $5.19 Million - $7.03 Million	754,780 Added 310.6%	997,786 $8.15 Million
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $1.1 Million - $2.63 Million	162,303 Added 201.11%	243,006 $2.05 Million
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $109,788 - $152,576	-6,879 Reduced 7.85%	80,703 $1.38 Million
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $759,917 - $1.17 Million	-48,557 Reduced 35.67%	87,582 $2.03 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $125,331 - $208,575	7,170 Added 5.56%	136,139 $2.4 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $2.2 Million - $3.6 Million	128,969 New	128,969 $3.51 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $252,041 - $378,061	-18,922 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $288,371 - $562,929	18,922 New	18,922 $321,000
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $3.46 Million - $4.77 Million	-121,257 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $426,041 - $642,445	14,098 Added 13.16%	121,257 $3.7 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $1.86 Million - $4.17 Million	79,163 Added 282.77%	107,159 $4.09 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $527,724 - $755,892	27,996 New	27,996 $644,000

Others Institutions Holding REPL

# of Institutions

153

Shares Held

70M

Call Options Held

26.7K

Put Options Held

28.6K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $540M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account